Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 273
8
Diseases
4
Unique genes
0.440
Avg. similarity score
Arterial calcification, generalized, of infancy, 1
Most-connected disease (7 links)
Disease
Searched: Arterial calcification, generalized, of infancy, 1
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Arterial calcification, generalized, of infancy, 1
Cole disease
Coronary medial sclerosis of infancy
Generalised arterial calcification of infancy and hypophosphatemic rickets
Hypopigmentation-punctate palmoplantar keratoderma syndrome
Crystal arthropathy
Hypophosphatemic rickets, autosomal recessive, 2
Ossification of the posterior longitudinal ligament of the spine
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Arterial calcification, generalized, of infancy, 1 | 7 | 7 | 1 |
| Cole disease | 7 | 7 | 1 |
| Coronary medial sclerosis of infancy | 7 | 7 | 1 |
| Generalised arterial calcification of infancy and hypophosphatemic rickets | 7 | 7 | 1 |
| Hypopigmentation-punctate palmoplantar keratoderma syndrome | 7 | 7 | 1 |
| Crystal arthropathy | 5 | 5 | 4 |
| Hypophosphatemic rickets, autosomal recessive, 2 | 5 | 5 | 1 |
| Ossification of the posterior longitudinal ligament of the spine | 5 | 5 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ENPP1 | 8 / 8 | Arterial calcification, generalized, of infancy, 1, Cole disease, Coronary medial sclerosis of infancy, Crystal arthropathy and 4 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Vitamin B2 (riboflavin) metabolism | Reactome | 1 / 7 | 429× | 2.33e-3 | 2.13e-2 ✓ sig. |
| Riboflavin metabolism | KEGG | 1 / 8 | 375× | 2.66e-3 | 2.34e-2 ✓ sig. |
| Vitamin B5 (pantothenate) metabolism | Reactome | 1 / 9 | 334× | 2.99e-3 | 2.54e-2 ✓ sig. |
| Heme degradation | Reactome | 1 / 14 | 214× | 4.66e-3 | 3.48e-2 ✓ sig. |
| Heme biosynthesis | Reactome | 1 / 14 | 214× | 4.66e-3 | 3.48e-2 ✓ sig. |
| Pantothenate and CoA biosynthesis | KEGG | 1 / 21 | 143× | 6.98e-3 | 4.53e-2 ✓ sig. |
| Iron uptake and transport | Reactome | 1 / 28 | 107× | 9.29e-3 | 5.43e-2 |
| Antifolate resistance | KEGG | 1 / 30 | 100× | 9.96e-3 | 5.67e-2 |
| Folate transport and metabolism | KEGG | 1 / 31 | 96.9× | 1.03e-2 | 5.79e-2 |
| Starch and sucrose metabolism | KEGG | 1 / 36 | 83.4× | 1.19e-2 | 6.32e-2 |
| Nicotinate and nicotinamide metabolism | KEGG | 1 / 38 | 79.0× | 1.26e-2 | 6.55e-2 |
| ABC transporters | KEGG | 1 / 45 | 66.7× | 1.49e-2 | 7.22e-2 |
| Pyrimidine metabolism | KEGG | 1 / 58 | 51.8× | 1.92e-2 | 8.36e-2 |
| Nucleotide metabolism | KEGG | 1 / 85 | 35.3× | 2.80e-2 | 1.04e-1 |
| Bile secretion | KEGG | 1 / 90 | 33.4× | 2.96e-2 | 1.07e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| negative regulation of hh target transcription factor activity | GO:1990787 | 1 / 1 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| biotin transport | GO:0015878 | 1 / 3 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| renal urate salt excretion | GO:0097744 | 1 / 3 | 1,557× | 6.42e-4 | 1.11e-2 ✓ sig. |
| inorganic diphosphate transport | GO:0030505 | 1 / 4 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| riboflavin transport | GO:0032218 | 1 / 6 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| xenobiotic transport across blood-brain barrier | GO:1990962 | 1 / 6 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| nucleoside triphosphate catabolic process | GO:0009143 | 1 / 6 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| nucleic acid metabolic process | GO:0090304 | 1 / 6 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| export across plasma membrane | GO:0140115 | 1 / 10 | 467× | 2.14e-3 | 2.19e-2 ✓ sig. |
| urate metabolic process | GO:0046415 | 1 / 10 | 467× | 2.14e-3 | 2.19e-2 ✓ sig. |
| negative regulation of glycogen biosynthetic process | GO:0045719 | 1 / 10 | 467× | 2.14e-3 | 2.19e-2 ✓ sig. |
| intracellular phosphate ion homeostasis | GO:0030643 | 1 / 10 | 467× | 2.14e-3 | 2.19e-2 ✓ sig. |
| urate transport | GO:0015747 | 1 / 11 | 425× | 2.35e-3 | 2.30e-2 ✓ sig. |
| transepithelial transport | GO:0070633 | 1 / 13 | 359× | 2.78e-3 | 2.51e-2 ✓ sig. |
| cellular detoxification | GO:1990748 | 1 / 14 | 334× | 2.99e-3 | 2.59e-2 ✓ sig. |